Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study
暂无分享,去创建一个
C. Holmes | D. Baldwin | C. Osmond | R. Hou | M. Garner | J. Teeling | L. Lau
[1] R. Dantzer,et al. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions , 2016, Molecular Psychiatry.
[2] Andrew H. Miller,et al. The role of inflammation in depression: from evolutionary imperative to modern treatment target , 2015, Nature Reviews Immunology.
[3] Ives Cavalcante Passos,et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. , 2015, The lancet. Psychiatry.
[4] N. Schmitz,et al. The longitudinal associations between C‐reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA) , 2015, International journal of geriatric psychiatry.
[5] M. Strippoli,et al. Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study , 2015, PloS one.
[6] O. Mors,et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. , 2014, JAMA psychiatry.
[7] Álvaro Camacho. Is anxious-depression an inflammatory state? , 2013, Medical hypotheses.
[8] M. Maes,et al. So depression is an inflammatory disease, but where does the inflammation come from? , 2013, BMC Medicine.
[9] D. Baldwin,et al. Potential neuroimmunological targets in the treatment of anxiety disorders. , 2013, Modern trends in pharmacopsychiatry.
[10] P. Mortensen,et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. , 2013, JAMA psychiatry.
[11] D. Wilcock,et al. Are inflammatory profiles the key to personalized Alzheimer's treatment? , 2013, Neurodegenerative disease management.
[12] P de Jonge,et al. Anxiety disorders and inflammation in a large adult cohort , 2013, Translational Psychiatry.
[13] D. F. Drake,et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.
[14] B. Bogerts,et al. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[15] M. Maes,et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways , 2012, BMC Medicine.
[16] E. Costello,et al. Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis , 2012, Psychological Medicine.
[17] M. Bloch,et al. Systematic Review of Proinflammatory Cytokines in Obsessive-Compulsive Disorder , 2012, Current Psychiatry Reports.
[18] L. Vécsei,et al. The kynurenine system and immunoregulation , 2012, Journal of Neural Transmission.
[19] V. Meyer-Rochow,et al. The association between anxiety and C-reactive protein (CRP) levels: Results from the Northern Finland 1966 Birth Cohort Study , 2011, European Psychiatry.
[20] J. Os,et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.
[21] Andrew H. Miller,et al. Immune system to brain signaling: neuropsychopharmacological implications. , 2011, Pharmacology & therapeutics.
[22] R. Andrade,et al. Enhanced Th17 phenotype in individuals with generalized anxiety disorder , 2010, Journal of Neuroimmunology.
[23] George M. Slavich,et al. Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion–biology relationships , 2010, Brain, Behavior, and Immunity.
[24] M. Schwarz,et al. Immune System and Schizophrenia. , 2010, Current immunology reviews.
[25] H. Westenberg,et al. Lipopolysaccharide-induced cytokine production in obsessive–compulsive disorder and generalized social anxiety disorder , 2010, Psychiatry Research.
[26] B. Wagner,et al. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals , 2010, Veterinary research.
[27] B. Morasco,et al. Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies , 2010, Neurobiology of Disease.
[28] Naomi I. Eisenberger,et al. Anger and fear responses to stress have different biological profiles , 2010, Brain, Behavior, and Immunity.
[29] Henry Völzke,et al. Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. , 2010, Journal of psychiatric research.
[30] J. Gill,et al. PTSD is associated with an excess of inflammatory immune activities. , 2009, Perspectives in psychiatric care.
[31] V. Seyfert-Margolis,et al. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays , 2009, BMC Immunology.
[32] N. Simon,et al. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder , 2009, Depression and anxiety.
[33] Charles L. Raison,et al. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.
[34] B. Leonard,et al. The psychoneuroimmunology of depression , 2009, Human psychopharmacology.
[35] M. Peck,et al. Th1/Th2 Patterns and Balance in Cytokine Production in the Parents and Infants of a Large Birth Cohort1 , 2009, The Journal of Immunology.
[36] J. Januzzi,et al. Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. , 2008, European heart journal.
[37] M G Marmot,et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study , 2008, Psychological Medicine.
[38] M. McGee,et al. Mental-physical comorbidity in an ethnically diverse population. , 2008, Social science & medicine.
[39] H. Wittchen,et al. Human and economic burden of generalized anxiety disorder , 2008, Depression and anxiety.
[40] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[41] M. Schwarz,et al. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression , 2007, Molecular Psychiatry.
[42] N. Müller,et al. Immunologische Aspekte bei depressiven Störungen , 2007, Der Nervenarzt.
[43] A. Steptoe,et al. The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis , 2007, Brain, Behavior, and Immunity.
[44] N. Atasoy,et al. Plasma Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Obsessive Compulsive Disorder , 2007, Mediators of inflammation.
[45] M. Schwarz,et al. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. , 2007, Journal of neural transmission. Supplementum.
[46] N. Müller,et al. [Immunological aspects of depressive disorders]. , 2007, Der Nervenarzt.
[47] C. Sommer,et al. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. , 2006, Arthritis and rheumatism.
[48] B. Löwe,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.
[49] D. Panagiotakos,et al. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. , 2006, Atherosclerosis.
[50] Andrew H. Miller,et al. Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.
[51] R. Kessler,et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. , 2004, JAMA.
[52] M. Maes,et al. Neuroimmunological parameters in panic disorder , 2004, Acta Neuropsychiatrica.
[53] S. Maier. Bi-directional immune–brain communication: Implications for understanding stress, pain, and cognition , 2003, Brain, Behavior, and Immunity.
[54] M. Kemeny. An interdisciplinary research model to investigate psychosocial cofactors in disease: Application to HIV-1 pathogenesis , 2003, Brain, Behavior, and Immunity.
[55] D. Witte,et al. Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. , 2002, The Journal of rheumatology.
[56] M. Fava,et al. The Anxiety Sensitivity Index: Item Analysis and Suggestions for Refinement , 2001, Journal of personality assessment.
[57] E. Bosmans,et al. Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production Ratio , 2001, Journal of clinical psychopharmacology.
[58] D. Remick,et al. Cytokines and the brain: implications for clinical psychiatry. , 2000, The American journal of psychiatry.
[59] Andreas Radbruch,et al. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. , 1999, Rheumatology.
[60] R. Weizman,et al. Cytokine production in panic disorder patients. , 1999, Clinical neuropharmacology.
[61] G. Marshall,et al. Cytokine Dysregulation Associated with Exam Stress in Healthy Medical Students , 1998, Brain, Behavior, and Immunity.
[62] M. Maj,et al. Decreased Blood Levels of Tumor Necrosis Factor-Alpha in Patients with Obsessive-Compulsive Disorder , 1998, Neuropsychobiology.
[63] E. Bosmans,et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. , 1998, Cytokine.
[64] D. Sheehan,et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.
[65] T. Tabuchi,et al. Immune function and lifestyle of taxi drivers in Japan. , 1998, Industrial health.
[66] A. von Ruecker,et al. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. , 1996, Surgery.
[67] Michael Maes,et al. Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[68] R. Ader,et al. Psychoneuroimmunology: interactions between the nervous system and the immune system , 1995, The Lancet.
[69] P. Sacerdote,et al. Plasma interleukin-1 beta concentrations in panic disorder , 1994, Psychiatry Research.
[70] P. Cosyns,et al. Immune disorders in depression: higher T helper/T suppressor‐cytotoxic cell ratio , 1992, Acta psychiatrica Scandinavica.
[71] E. Bosmans,et al. Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[72] E. Bosmans,et al. Depression‐related disturbances in mitogen‐induced lymphocyte responses and interleukin‐1β and soluble interleukin‐2 receptor production , 1991, Acta psychiatrica Scandinavica.
[73] E. Bosmans,et al. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. , 1990, Neuropsychobiology.
[74] R. Snaith,et al. The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.
[75] T. Kamarck,et al. A global measure of perceived stress. , 1983, Journal of health and social behavior.
[76] R Ader,et al. Behaviorally Conditioned Immunosuppression , 1974, Psychosomatic medicine.